LTR Pharma Makes SPONTAN Product Available Through Pharmacy Network, Shares Jump 38%

MT Newswires Live
05-20

LTR Pharma (ASX:LTP) said its SPONTAN nasal spray product will be available through TerryWhite Chemmart's pharmacy network in Australia under its earlier distribution agreement with Symbion, according to a Tuesday Australian bourse filing.

TerryWhite Chemmart is a subsidiary of EBOS Group (ASX:EBO, NZE:EBO) alongside Symbion, the filing said.

LTR Pharma developed new commercial packaging for the SPONTAN intranasal spray, designed for pharmacy distribution and incorporating Therapeutic Goods Administration-compliant labeling, patient information materials, and pharmacy-standard barcodes.

The expanded pharmacy rollout will allow the firm to gather real-world data on SPONTAN usage to support its regulatory strategy and preparations for a full commercial launch following regulatory approval in Australia.

Its shares jumped over 38% in recent trading on Tuesday.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10